DGX
Quest Diagnostics · Health Care
6.7%
typical move (median |reaction| of last 8)
2026-10-20 pre · likely
next expected · estimated from pattern
12
scored events
Last eight reactions
2024-10-22 → 2026-07-23
| date | session | reaction | |move| | excess 5s | excess 20s |
|---|---|---|---|---|---|
| 2026-07-23 | pre | +8.4% | 8.4% | +2.5% | +2.6% |
| 2026-04-21 | pre | +4.4% | 4.4% | -6.1% | -11.5% |
| 2026-02-10 | pre | +7.2% | 7.2% | +0.4% | +0.0% |
| 2025-10-21 | pre | -3.0% | 3.0% | -5.8% | +2.0% |
| 2025-07-22 | pre | +7.0% | 7.0% | -6.8% | +0.9% |
| 2025-04-22 | pre | +6.7% | 6.7% | -1.9% | -9.4% |
| 2025-01-30 | pre | +5.6% | 5.6% | -1.3% | +7.1% |
| 2024-10-22 | pre | +6.7% | 6.7% | -0.5% | +1.3% |
Source filings
2026-07-23 · 8-K press release
Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 • Second quarter revenues of $3.04 billion, up 10.2% from 2025, with 10.0% organic r
2026-04-21 · 8-K press release
Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 • First quarter revenues of $2.90 billion, up 9.2% from 2025, with 9.0% organic reven
2026-02-10 · 8-K press release
Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share • Fourth quarter revenues of $
2025-10-21 · 8-K press release
Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 • Third quarter revenues of $2.82 billion, up 13.1% from 2024 • Third quarter reported diluted earnin
2025-07-22 · 8-K press release
Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 • Second quarter revenues of $2.76 billion, up 15.2% from 2024 • Second quarter reported diluted ear
2025-04-22 · 8-K press release
Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 • First quarter revenues of $2.65 billion, up 12.1% from 2024 • F
2025-01-30 · 8-K press release
Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share • Fourth quarter revenues of $
2024-10-22 · 8-K press release
Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024 • Third quarter revenues of $2.49 billion, up 8.5% from 2023 • Third quarter reported diluted earnin